Dominic Moorhead

Executive Board
 R & D
Ferring Pharmaceuticals
Portugal

Business Expert Reproductive Medicine
Biography

 Dominic Moorhead joined Ferring in July 2017 as Chief Financial Officer (CFO).   Moorhead has 30 years’ finance and business experience in the life sciences industry. For the past year, he has been a strategic advisor to executives and investors in biotech. Previously, he worked for Takeda Pharmaceuticals as Global Financial Controller, and CFO of the international business following the acquisition of Nycomed. Prior to this he worked for Hoffmann-La Roche, where he was CFO of the Pharma Division for nine years during a period of transformation and growth. He was engaged in numerous strategic initiatives and business transactions, as well as their operational implications, culminating in the privatisation of Genentech in the U.S. in 2009.   Moorhead has an ACA from Institute of Chartered Accountants in England and Wales and a BSc in  Chemistry from the University of Nottingham.

Research Intrest

   R & D